Segall Bryant & Hamill, LLC Charles River Laboratories International, Inc. Transaction History

Segall Bryant & Hamill, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$183.71 - $210.25 $190,507 - $218,029	-1,037 Reduced 11.13%	8,277 $1.74 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $356,723 - $483,191	-1,859 Reduced 16.64%	9,314 $1.88 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $2.62 Million - $3.32 Million	-13,283 Reduced 54.31%	11,173 $2.43 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $16.8 Million - $23 Million	-91,888 Reduced 78.98%	24,456 $4.83 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $8.39 Million - $12.4 Million	-41,117 Reduced 26.11%	116,344 $24.9 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $1.61 Million - $2.28 Million	-6,298 Reduced 3.85%	157,461 $44.7 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $1.48 Million - $1.9 Million	-4,224 Reduced 2.51%	163,759 $61.7 Million
Q3 2021 Nov 03, 2021	SELL	$372.64 - $458.3 $435,988 - $536,211	-1,170 Reduced 0.69%	167,983 $69.3 Million
Q2 2021 Aug 12, 2021	BUY	$294.17 - $371.65 $10.1 Million - $12.7 Million	34,241 Added 25.38%	169,153 $62.6 Million
Q1 2021 May 13, 2021	BUY	$249.67 - $299.48 $680,101 - $815,783	2,724 Added 2.06%	134,912 $39.1 Million
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $6.77 Million - $7.7 Million	30,496 Added 29.99%	132,188 $33 Million
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $3.09 Million - $3.99 Million	17,600 Added 20.93%	101,692 $23 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $9.99 Million - $16 Million	84,092 New	84,092 $14.7 Million

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.